Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by Ventura2020on Oct 16, 2020 8:24pm
143 Views
Post# 31733150

RE:What I would like to see happen.

RE:What I would like to see happen.

ProfCornelius wrote: First of all, the optics of Irwin Simon's BNN "interview " yesterday were simply putrid. What I saw was a guy who portrayed himself as ill prepared, unkept, melancholy and uninspiring. I hope that this performance was by design as to give the shorts comfort just before a deal is to be announced but that would be giving him to much credit and I won't hold my breath. The truth is that many people are slacking severely and have been underperformers during this Covid crisis and I believe that may be the case for Aphrias overpriced CEO. That being said, something tells me a deal will happen with either Canopy or an MSO. Canopy has definitely reached out to Aphria but Aphria walked. Possibly even twice. IMHO, I believe Canopy will be back with a better offer because they need us. The problem I see is this. If I am making oodles of cash as a part time CEO and using that capital to front other projects I am not leaving quietly unless the acquisition of Aphria is beyond a fair deal. I would accept a fair deal for the acquisition of Aphria as most shareholders would be why would he? He has it way way too good fellow shareholders. He has gotten waaaaaay to comfortable in that CEO seat that he only occasionally sits in and yesterday clearly told that tale. Read about a term called "deviation drift" because that's what we are experiencing with him here!!! Now back to my subject line. What I would like to see happen by the end of the year is an announcement confirming a merger arranged with a MSO and Aphria that becomes binding once cannabis is federally legalized in the states. Between then and now all of the pertinent details could be worked out while also making our share price go parabolic. I have some faith that as a contingency I S has been exploring this opportunity but ffs Irwin get your act together public relations wise. Atleast speak, act and appear that you care. My choice for an eventual merger with a MSO is Cresco Labs. I don't speak about it much but I've been a shareholder since the huge Covid dip in the spring. These two companies would be the perfect fit. Regards, Prof

 

Good read!

I like the thought of Creaco Labs as well ( I believe Vic said the same words not so long ago in an interview) and yes, wait until legalization. No point going in now when you have no way of knowing which way this election may go. Best hold up and have discussions and wait for the right entry point. 

Ventura

<< Previous
Bullboard Posts
Next >>